中文

津膜科技 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-24
ItemAmountY/Y
Revenue¥0.09B+81.2%
Gross profit¥0.02B
Operating income¥0.00B
Net income¥0.00B+13.0%
Gross margin24.8%Net margin 2.6%
Revenue Q/Q+12.7%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.07B75.2%
R&D¥0.01B7.6%
SG&A¥0.01B16.0%
Tax & other¥0.00B0.3%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

迪森股份银邦股份*ST开元润和软件科恒股份麦克奥迪天银机电联创股份华民股份南大光电泰格医药长亮科技

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies